Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Brera Slmt Stock Good For Active Traders Price At 0.81 Down 2.30 20260408 Is Sumitomo Smfg Stock Attractive Now Price At 20.43 Down 0.02 20260406 How Is Tmc The Tmc Stock Performing In 2026 Price At 4.66 Up 5.56 20260408 Is Gamehaus Gmhs Stock Testing Resistance Price At 0.95 Down 0.69 20260413 Daily Market Overview Sp500 Nasdaq Edge Up Dow Slips In Mixed Trading 20260408 1 Is Contango Ore Ctgo Stock Leading The Market Price At 19.05 Down 2.76 20260406 Can Next Nxtt Stock Double In 2026 Price At 1.79 Down 10.05 20260407 Will Chunghwa Tel Cht Stock Miss Expectations Price At 42.53 Up 0.28 20260406 Will Distnow Dnow Stock Outperform S P 500 Price At 12.18 Up 0.83 20260406 Walt Disney Co DIS Faces Material Patent Infringement Risks in InterDigital Q1 2026 Earnings Update Merck Co MRK Upgraded 2026 Guidance and HIV Drug Approval Reinforce But Do Not Reshape LongTerm Investment Thesis CRBU Caribou Bio Q4 2025 EPS beats estimates by 114 percent but shares fall 769 percent today SP Global Inc SPGI SP Global Ratings Upgrades Adeia Inc ADEA Issuer Credit Rating to BB with Stable Outlook NNBR NN misses Q4 2025 EPS estimates positive investor sentiment lifts shares six percent higher Devon Energy Corporation DVN Upcoming Q1 2026 Earnings Face Bearish Headwinds Amid Peer Margin Pressure What Keros Therapeutics KROS does that makes it resilient Flat 20260506 The MA impact hidden in SANUWAVE Health SNWV earnings Q4 2025 Profit Exceeds Views When is UBS Group UBS next earnings date and what matters most UBS Group delivers 52 EPS beat on core wealth management strength iShares MSCI Germany ETF EWG Rides 2025 Global Equity Rally That Outpaces Lagging US Benchmarks loanDepot LDI Market Conditions Q4 2025 Earnings Underperform DexCom Inc DXCM Bullish Thesis Highlights Recurring Revenue Moat CatalystDriven Upside Amid Recent Pullback Fidelity FNF Stock Outlook and Catalysts Q4 2025 EPS Misses Estimates CLDX Celldex reports wider Q4 2025 pershare loss than consensus estimates stock gains 157 percent today